Bharat Biotech begins COVID vaccine#39;s late-stage human testing involving 26000 volunteers

Bharat Biotech on November 16 announced the commencement of Phase-III trials of its COVID-19 vaccine Covaxin.
The Phase-III trials will involve 26,000 volunteers across India, conducted in partnersh… [read more]

Leave a Comment